Scintigraphic Manifestations of Thyrotoxicosis

Radiographics

Volumn 23, Issue 4, 2003, Pages 857-869

  Intenzo, Charles M ^a   DePapp, Anne E ^a   Jabbour, Serge ^a   Miller, Jeffrey L ^a   Kim, Sung M ^a   Capuzzi, David M ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Thyroid, 273.58, 273.64; Thyroid, hyperthyroidism, 273.522; Thyroid, radionuclide studies, 273.1217; Thyroiditis, 273.292

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; CONTRAST MEDIUM; IODINE 123; IODINE 131; LIOTHYRONINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERTECHNETIC ACID TC 99M; POTASSIUM PERCHLORATE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; SALICYLIC ACID DERIVATIVE; STEROID; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROXINE;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GRAVES DISEASE; HASHIMOTO DISEASE; HEART ARRHYTHMIA; HORMONE SYNTHESIS; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IODINE 131 UPTAKE TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PROGNOSIS; REVIEW; SUBACUTE THYROIDITIS; SYMPTOMATOLOGY; TERATOMA; THYROID CANCER; THYROID FUNCTION; THYROID GLAND; THYROID SCINTISCANNING; THYROIDITIS; THYROTOXICOSIS; TOXIC GOITER; ADULT; AGED; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; THYROTOXICOSIS;

EID: 0042343823     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.234025716     Document Type: Review

References (34)

1. Ridgway EC. Clinical evaluation of solitary thyroid nodules. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 8th ed. Philadelphia, Pa: Lippincott-Raven, 2000; 949-956.
2. Eisenberg B, Arrington ER, Haygood TM, Kelsey CA. Thyroid scintigraphic patterns, radioactive iodine uptake, and Nuclear Regulatory Commission guidelines for radioiodine use. In: Eisenberg B, ed. Imaging of thyroid and parathyroid glands: a practical guide. New York, NY: Churchill Livingstone, 1991; 51-57.
3. Zakarija M, McKenzie J, Banoviac K. Clinical significance of thyroid-stimulating antibody in Graves' disease. Ann Intern Med 1980; 93:28-32.
4. Harbert JC. Radioiodine therapy of hyperthyroidism. In: Harbert JC, Eckelman WC, Neumann RD, et al. Nuclear medicine: diagnosis and therapy. New York, NY: Thieme Medical, 1996; 959-973.
5. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990; 70:1518-1524.
6. Hedley AJ, Young RE, Jones SJ, et al. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Clin Endocrinol 1989; 31:209-218.
7. Charkes ND. Graves' disease with functioning nodules (Marine-Lenhart syndrome). J Nucl Med 1972; 13:885-892.
8. Davies TF, Larsen PR. Thyrotoxicosis. In: Larsen PR, Kronenberg HM, Melmed S, Polansky KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia, Pa: Saunders, 2003; 374-455.
9. VanSande J, Lamy F, Lecocq R, et al. Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. J Clin Endocrinol Metab 1988; 66:570-589.
10. Corvilain B, Dumont J, Vassart G. Toxic adenoma and toxic multinodular goiter. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 8th ed. Philadelphia, Pa: Lippincott-Raven, 2000; 564-572.
11. Goldstein R, Hart IR. Follow-up of solitary autonomous thyroid nodules treated with 131I. N Engl J Med 1983; 309:1473-1476.
12. Clerc J, Dagousset F, Izembart M, et al. Radioiodine therapy of the autonomous thyroid nodule in patients with and without visible extranodular activity. J Nucl Med 1995; 36:217-223.
13. Peter HJ, Gerber H, Studer H, et al. Pathogenesis of heterogeneity in human multinodular goiter. J Clin Invest 1985; 76:1992-2002.
14. Van Soestbergen MJM, Van der Vijver JCM, Graafland AD. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease. J Endocrinol Invest 1992; 15:797-800.
15. Thomas CG Jr, Croom RD. Current management of the patient with autonomously functioning nodular goiter. Surg Clin North Am 1987; 67: 315-328.
16. Volpe R. Subacute thyroiditis. In: Burrow GN, Oppenheimer JH, Volpe R, eds. Thyroid function and disease. Philadelphia, Pa: Saunders, 1989; 179-187.
17. Volpe R. The management of subacute (de Quervain's) thyroiditis. Thyroid 1993; 3:253-257.
18. Hamburger JI. The various presentations of thyroiditis: diagnostic considerations. Ann Intern Med 1986; 104:219-224.
19. Nikolai TF, Brosseau J, Kettrick MA, et al. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Intern Med 1980; 140:478-482.
20. Nikolai TF, Combs GJ, McKenzie AK, et al. Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Intern Med 1982; 142:2281-2283.
21. Martins ML, Lima N, Knobel M, et al. Natural course of iodine-induced thyrotoxicosis (Jod Basedow) in endemic goiter area: a 5 year follow-up. J Endocrinol Invest 1989; 12:239-244.
22. Vagenalsis AG, Wang CA, Burger A, et al. Iodine-induced thyrotoxicosis in Boston. N Engl J Med 1972; 287:523-527.
23. Seminara MD, Daniels GH. Amiodarone and the thyroid. Endocr Pract 1998; 4:48-54.
24. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 1987; 26:227-237.
25. Reichert LJ, deRooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ 1989; 298:1547-1548.
26. Brousolle C, Ducotett X, Martin C, et al. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis: comparison of two groups of patients with apparently normal thyroid glands. J Endocrinol Invest 1989; 12:37-42.
27. Eliason BC, Doenier JA, Nuhlicek DN. Desiccated thyroid in a nutritional supplement. J Fam Pract 1994; 38:287-288.
28. Hedberg CW, Fishbein DB, Janssen RS, et al. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef. N Engl J Med 1987; 316:993-998.
29. Cohen JH, Inbar SH, Braverman LE. Thyrotoxicosis due to ingestion of excess thyroid hormone. Endocr Rev 1989; 10:113-124.
30. Steffenson FH, Aunsholt NA. Hyperthyroidism associated with metastatic thyroid carcinoma. Clin Endocrinol 1994; 41:685-687.
31. McDougall IR. Hyperthyroidism. In: Thyroid disease in clinical practice. New York, NY: Oxford University Press, 1992; 82-162.
32. Desai RK, Norman RJ, Jialal I, Joubert SM. Spectrum of thyroid function abnormalities in gestational trophoblastic neoplasia. Clin Endocrinol 1988; 29:583-592.
33. Smallridge RC, Smith CE. Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Arch Intern Med 1983; 143:503-507.
34. Intenzo CM, Capuzzi DM, Jabbour S, Kim SM, dePapp AE. Scintigraphic features of autoimmune thyroiditis. RadioGraphics 2001; 21:957-964.